Edition:
United Kingdom

People: Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

194.99USD
18 May 2018
Change (% chg)

$3.85 (+2.01%)
Prev Close
$191.14
Open
$191.47
Day's High
$195.15
Day's Low
$190.80
Volume
154,912
Avg. Vol
106,853
52-wk High
$195.15
52-wk Low
$107.70

Gray, Nancy 

Dr. Nancy Ryan Gray, Ph.D., is Director of the Company. Dr. Gray currently serves as President and Chief Executive Officer of Gordon Research Conferences, a not-for-profit organization that arranges conferences in the biological, chemical, and physical sciences worldwide. Prior to joining Gordon Research Conferences in 2003, for nine years Dr. Gray was with the American Chemical Society (ACS) in Washington, D.C., the world's largest scientific society, most recently as Director of Membership. She also was the liaison to the Board Committee on Grants and Awards and the Council Committee on Nominations and Elections, and was responsible for the ACS national election process. Prior to joining Gordon Research Conferences in 2003, for nine years Dr. Gray was with the American Chemical Society (ACS) in Washington, D.C., the world's largest scientific society, most recently as Director of Membership. Dr. Gray received her B.S. in Chemistry from the University of Notre Dame in 1981 and her Ph.D. in Fuel Science from The Pennsylvania State University in 1985.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Kozarich

296,271

Matthew Foehr

2,841,260

John Higgins

5,352,640

Matthew Korenberg

1,966,840

Charles Berkman

1,300,170

Nancy Gray

--
As Of  31 Dec 2016